Literature DB >> 33316293

Divergent profiles of fentanyl withdrawal and associated pain in mice and rats.

Olivia Uddin1, Carleigh Jenne1, Megan E Fox1, Keiko Arakawa1, Asaf Keller1, Nathan Cramer2.   

Abstract

Opioid abuse has devastating effects on patients, their families, and society. Withdrawal symptoms are severely unpleasant, prolonged, and frequently hinder recovery or lead to relapse. The sharp increase in abuse and overdoses arising from the illicit use of potent and rapidly-acting synthetic opioids, such as fentanyl, highlights the urgency of understanding the withdrawal mechanisms related to these drugs. Progress is impeded by inconsistent reports on opioid withdrawal in different preclinical models. Here, using rats and mice of both sexes, we quantified withdrawal behaviors during spontaneous and naloxone-precipitated withdrawal, following two weeks of intermittent fentanyl exposure. We found that both mice and rats lost weight during exposure and showed increased signs of distress during spontaneous and naloxone precipitated withdrawal. However, these species differed in their expression of withdrawal associated pain, a key contributor to relapse in humans. Spontaneous or ongoing pain was preferentially expressed in rats in both withdrawal conditions, while no change was observed in mice. In contrast, withdrawal associated thermal hyperalgesia was found only in mice. These data suggest that rats and mice diverge in how they experience withdrawal and which aspects of the human condition they most accurately model. These differences highlight each species' strengths as model systems and can inform experimental design in studies of opioid withdrawal.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33316293      PMCID: PMC8065268          DOI: 10.1016/j.pbb.2020.173077

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  77 in total

1.  Gender- and morphine dose-linked expression of spontaneous somatic opiate withdrawal in mice.

Authors:  Francesco Papaleo; Angelo Contarino
Journal:  Behav Brain Res       Date:  2006-03-31       Impact factor: 3.332

2.  Characterizing opioid withdrawal during double-blind buprenorphine detoxification.

Authors:  Kelly E Dunn; Kathryn A Saulsgiver; Mollie E Miller; Paul A Nuzzo; Stacey C Sigmon
Journal:  Drug Alcohol Depend       Date:  2015-03-12       Impact factor: 4.492

3.  Compulsive-Like Sufentanil Vapor Self-Administration in Rats.

Authors:  Janaina C M Vendruscolo; Brendan J Tunstall; Stephanie A Carmack; Brooke E Schmeichel; Emily G Lowery-Gionta; Maury Cole; Olivier George; Sophia A Vandewater; Michael A Taffe; George F Koob; Leandro F Vendruscolo
Journal:  Neuropsychopharmacology       Date:  2017-08-16       Impact factor: 7.853

4.  Thermal sensitivity across ages and during chronic fentanyl administration in rats.

Authors:  Jeremiah D Mitzelfelt; Christy S Carter; Drake Morgan
Journal:  Psychopharmacology (Berl)       Date:  2013-07-31       Impact factor: 4.530

5.  Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat.

Authors:  S A Dunbar; I J Pulai
Journal:  J Pharmacol Exp Ther       Date:  1998-02       Impact factor: 4.030

6.  Pharmacokinetics of naloxone in rats and in man: basis for its potency and short duration of action.

Authors:  S H Ngai; B A Berkowitz; J C Yang; J Hempstead; S Spector
Journal:  Anesthesiology       Date:  1976-05       Impact factor: 7.892

7.  Potential risk factors associated with risk for drop-out and relapse during and following withdrawal of opioid prescription medication.

Authors:  Susanne Heiwe; Ingeborg Lönnquist; Håkan Källmén
Journal:  Eur J Pain       Date:  2011-05-04       Impact factor: 3.931

8.  Hyperalgesia during acute opioid abstinence: evidence for a nociceptive facilitating function of the rostral ventromedial medulla.

Authors:  H Kaplan; H L Fields
Journal:  J Neurosci       Date:  1991-05       Impact factor: 6.167

9.  Morphine-induced hyperactivity in rats--a rebound effect?

Authors:  B Magnus-Ellenbroek; U Havemann-Reinecke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-06       Impact factor: 3.000

10.  Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia.

Authors:  David D Hood; Regina Curry; James C Eisenach
Journal:  Anesth Analg       Date:  2003-09       Impact factor: 5.108

View more
  2 in total

Review 1.  Cellular Tolerance Induced by Chronic Opioids in the Central Nervous System.

Authors:  Sweta Adhikary; John T Williams
Journal:  Front Syst Neurosci       Date:  2022-06-28

Review 2.  Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse.

Authors:  Ying Han; Lu Cao; Kai Yuan; Jie Shi; Wei Yan; Lin Lu
Journal:  Neurosci Bull       Date:  2022-05-15       Impact factor: 5.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.